A Possible Effect of Oxytocin During Interaction Between Humans and Animals

Animal Assisted Therapy Clinical Trial

— Oxytocin2010  

Official title:

A Possible Effect of Oxytocin During Interaction Between Humans and Animals

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01226017
• Other study ID #: 2010/1589
• Status: Completed
• Phase: N/A
• First received: October 20, 2010
• Last updated: November 22, 2011
• Start date: October 2010
• Est. completion date: November 2011

Study information

• Verified date: November 2011
• Source: Norwegian University of Life Sciences
• Contact: n/a
• Is FDA regulated: No
• Health authority: Norway:National Committee for Medical and Health Research Ethics
• Study type: Interventional

Clinical Trial Summary

The purpose of this pilot study is to investigate the possible change of Oxytocin level in human blood after positive interaction with farm animals.

Description:

The purpose of this pilot study is to investigate the possible change of Oxytocin level in human blood after positive interaction with farm animals and filling in instruments measuring anxiety and stress.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 18
• Est. completion date: November 2011
• Est. primary completion date: November 2011
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 20 Years to 30 Years

Eligibility

Inclusion Criteria:

• woman

• age 20-30 years old

• physical capable of being in a farm environment and have contact with cows

Exclusion Criteria:

• pregnancy

• breastfeeding

• anxiety for blood sampling

• anxiety for animals

• allergies

• psychiatric diagnoses

• medication

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

• Animal Assisted Therapy

Intervention

Other:
• Measuring oxytocin level in blood
Blood sampling and instruments measuring anxiety and stress

Locations

Country	Name	City	State
Norway	Norwegian University of Life sciences	Aas

Sponsors (1)

Lead Sponsor	Collaborator
Norwegian University of Life Sciences

Country where clinical trial is conducted

Norway, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Measuring the possible change in Oxytocin level in human blood during intervention with farm animals.	Blood sampling will be drawn at baseline, before intervention starts, and 5 minutes after start. 3rd sample will be drawn 15 minutes after start. Total time of intervention is 15 minutes.	Start medio October 2010, and end December 2011 (14 months)	No
Secondary	Self evaluation of anxiety and coping strategies.	Spielberger State Anxiety Inventory (SSAI) (Spielberger et al, 1979)and Coping Strategies Scale of the Pressure Management Indicator (Williams & Cooper, 1998.	Start medio October 2010, and end December 2011 (14 months)	No